Seer, Inc. (SEER)
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
$108.12M
Dr. Omid C. Farokhzad M.D., Ph.D.
118.00
Redwood City, CA
Dec 04, 2020
-1.37
$-1.28
3.57
21.22
-576.89%
-1.19
0.25
6.90
20.66
-18.77%
-19.72%
Similar stocks (18)
Kymera Therapeutics, Inc.
KYMR
Nurix Therapeutics, Inc.
NRIX
Cullinan Oncology, Inc.
CGEM
Sana Biotechnology, Inc.
SANA
ORIC Pharmaceuticals, Inc.
ORIC
Foghorn Therapeutics Inc.
FHTX
C4 Therapeutics, Inc.
CCCC
Lyell Immunopharma, Inc.
LYEL
Monte Rosa Therapeutics, Inc.
GLUE
Nkarta, Inc.
NKTX
PepGen Inc.
PEPG
Generation Bio Co.
GBIO
Shattuck Labs, Inc.
STTK
Quantum-Si incorporated
QSI
MediciNova, Inc.
MNOV
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
ETF Exposure (14)
iShares Micro-Cap ETF
IWC
0.02586%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.016%
Schwab U.S. Small-Cap ETF
SCHA
0.002076261%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (18)
Kymera Therapeutics, Inc.
KYMR
Nurix Therapeutics, Inc.
NRIX
Cullinan Oncology, Inc.
CGEM
Sana Biotechnology, Inc.
SANA
ORIC Pharmaceuticals, Inc.
ORIC
Foghorn Therapeutics Inc.
FHTX
C4 Therapeutics, Inc.
CCCC
Lyell Immunopharma, Inc.
LYEL
Monte Rosa Therapeutics, Inc.
GLUE
Nkarta, Inc.
NKTX
PepGen Inc.
PEPG
Generation Bio Co.
GBIO
Shattuck Labs, Inc.
STTK
Quantum-Si incorporated
QSI
MediciNova, Inc.
MNOV
Anebulo Pharmaceuticals, Inc.
ANEB
AN2 Therapeutics, Inc.
ANTX
HCW Biologics Inc.
HCWB
ETF Exposure (14)
iShares Micro-Cap ETF
IWC
0.02586%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.016%
Schwab U.S. Small-Cap ETF
SCHA
0.002076261%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Health Care Index Fund
VHT
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%